您的位置: 首页 > 农业专利 > 详情页

ARTEMISININ-BASED COMBINATION THERAPY FOR TREATING VIRAL MEDIATED DISEASE
专利权人:
ROBERT LEWIS STEELE;KRYPTONITE GROUP, LTD.;KRYPTONITE GROUP; LTD.
发明人:
STEELE, ROBERT LEWIS,MUSSO, ANTHONY FEDELE,MUNDSCHENK, DAVID D,VAN DE CASTEELE. RUSSELL
申请号:
PH12014501601
公开号:
PH12014501601A1
申请日:
2014.07.11
申请国别(地区):
PH
年份:
2015
代理人:
摘要:
The present invention describes a method of treating individuals suffering from microbial infections, including a viral infection such as Dengue Fever, using an improved Artemisinin Combination Therapy (ACT), known as Tri-ACT. The improved ACT therapy includes administering a combination of three drugs. In one embodiment of the present invention, the method includes administering to an individual a first composition comprising a therapeutically effective amount of an artemether spray sublingually. The individual is then administered a second compositions, a therapeutically effective amount of artesunate. A third compositon, an effective amount of berberine, or its pharmaceutically acceptable derivatives or salts is then administered to the individual.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充